Insider Transactions in Q3 2025 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2025
|
Curran Simpson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,734
-3.07%
|
$77,340
$10.02 P/Share
|
|
Sep 01
2025
|
Mitchell Chan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,901
-8.33%
|
$39,208
$8.93 P/Share
|
|
Sep 01
2025
|
Craig Malzahn Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
234
-1.31%
|
$1,872
$8.93 P/Share
|
|
Aug 01
2025
|
Patrick J. Christmas Chief Strategy & Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,699
-3.01%
|
$37,592
$8.19 P/Share
|
|
Jul 01
2025
|
Curran Simpson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,701
-1.83%
|
$37,608
$8.23 P/Share
|